Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Public ClinicalTrials.gov record NCT00527735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination With Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine whether ipilimumab given with paclitaxel/carboplatin has clinical benefit when compared with paclitaxel/carboplatin alone in patients with previously untreated lung cancer.
Study identification
- NCT ID
- NCT00527735
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 334 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Jul 18, 2018
2008 – 2011
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology & Oncology Assoc. Llc | Birmingham | Alabama | 35235 | — |
| Mayo Clinic | Scottsdale | Arizona | 85259 | — |
| Acrc/Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85715 | — |
| Compassionate Cancer Care Medical Group | Corona | California | 92879 | — |
| Compassionate Cancer Care Medical Group, Inc. | Fountain Valley | California | 92708 | — |
| The Angeles Clinic & Research Institute, Inc | Los Angeles | California | 90025 | — |
| Oncology Care Medical Associates | Montebello | California | 90640 | — |
| Compassionate Cancer Care Medical Group | Riverside | California | 92501 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| M D Anderson Cancer Center- Orlando | Orlando | Florida | 32806 | — |
| Georgia Cancer Specialists | Atlanta | Georgia | 30341 | — |
| University Of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Local Institution | Park Ridge | Illinois | 60068 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| The John R. Marsh Cancer Center | Hagerstown | Maryland | 21740 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| The Cancer Center | Minneapolis | Minnesota | 55455 | — |
| Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Local Institution | New York | New York | 10017 | — |
| Cmc-Northeast/ Northeast Oncology Associates | Concord | North Carolina | 28025 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Hematology Oncology Consultants, Inc | Columbus | Ohio | 43235 | — |
| St. Mary Medical Center | Langhorne | Pennsylvania | 19047 | — |
| Guthrie Clinical Research | Sayre | Pennsylvania | 18840 | — |
| Santee Hematology/Oncology | Sumter | South Carolina | 29150 | — |
| Southwest Cancer Treatment And Research Center | Lubbock | Texas | 79415 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00527735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2018 · Synced Oct 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00527735 live on ClinicalTrials.gov.